FTXH news

First Trust Nasdaq Pharmaceuticals · Pharmaceuticals · United States

Stories about this fund's companies, ranked by fund weight and recency. Times are local.

Quartz · 28 Oct 2026, 16:16 UTC
Best-selling drugs 2026: 7 of the top 10 by 2025 sales
24.1% of FTXH
Yahoo! Finance · 28 Oct 2026, 07:29 UTC
The Zacks Analyst Blog Highlights Eli Lilly, Novartis, Johnson & Johnson and AbbVie
22.1% of FTXH
Benzinga · 28 Oct 2026, 19:32 UTC
Traders Are Pricing a 7% Swing in Amazon Ahead of Earnings - Amazon.com (NASDAQ:AMZN), Intel (NASDAQ:INTC
13.4% of FTXH
Seeking Alpha · 28 Oct 2026, 15:55 UTC
Pharma giants Merck, Eli Lilly face earnings health check (MRK:NYSE) | Seeking Alpha
14.8% of FTXH
Where to buy FTXH
- [Broker A]Visit ↗
- [Broker B]Visit ↗
[Affiliate and risk wording from the law firm]
24/7 Wall St. · 28 Oct 2026, 12:14 UTC
3 Big Pharma Earnings Reports to Watch: Eli Lilly, Merck and Gilead
14.8% of FTXH
Quartz · 28 Oct 2026, 14:15 UTC
New weight-loss drugs: what 6 drugmakers are testing
13.9% of FTXH
Where to buy FTXH
- [Broker A]Visit ↗
- [Broker B]Visit ↗
[Affiliate and risk wording from the law firm]
Yahoo! Finance · 27 Oct 2026, 13:47 UTC
What's in Store for These 5 Drug/Biotech Stocks in Q3 Earnings?
21.1% of FTXH
24/7 Wall St. · 28 Oct 2026, 19:24 UTC
16% of Employers Are Thinking About Cutting Weight-Loss Drug Coverage
7.8% of FTXH
TheStreet · 28 Oct 2026, 19:33 UTC
Breakthrough cancer vaccine catches Wall Street's attention
7.7% of FTXH
24/7 Wall St. · 28 Oct 2026, 16:04 UTC
Moderna Jumps 4% Despite William Blair Downgrade on Valuation; Novavax and BioNTech Edge Higher
7.7% of FTXH
Yahoo! Finance · 28 Oct 2026, 16:03 UTC
This Dividend Powerhouse Is Heading Into Q3 Earnings With Plenty at Stake
7.4% of FTXH
Benzinga · 28 Oct 2026, 13:25 UTC
Eli Lilly Says Retatrutide Delivers More Than Double Ozempic's Weight Loss in Late-Stage Diabetes Trial -
7.8% of FTXH
Yahoo! Finance · 27 Oct 2026, 15:16 UTC
4 Arthritis Drug Stocks Investors Should Monitor for Growth Potential
14.7% of FTXH
Market Screener · 28 Oct 2026, 12:07 UTC
Eli Lilly And Company Announces Positive Topline Results From TRANSCEND-T2D-2 Phase 3 Trial Of Retatrutide In Adults With Type 2 Diabetes
7.8% of FTXH
Benzinga · 28 Oct 2026, 10:04 UTC
Top Wall Street Forecasters Revamp Eli Lilly Expectations Ahead Of Q3 Earnings - Eli Lilly (NYSE:LLY)
7.8% of FTXH
Seeking Alpha · 28 Oct 2026, 08:28 UTC
AbbVie: Still Strong Growth, But Patent Cliff Getting Closer (NYSE:ABBV) | Seeking Alpha
7.4% of FTXH
allAfrica · 28 Oct 2026, 05:11 UTC
Nigeria Health Watch and ACIOE Foundation Launch New Phase of Maternal Health Advocacy Project to Advance Policy Action and Investment in Nigeria
7.1% of FTXH
www.theepochtimes.com · 28 Oct 2026, 00:00 UTC
Judge Declines to Block Eli Lilly Weight-Loss Drug Ads in Dispute With Novo Nordisk
7.8% of FTXH
Business Insider · 28 Oct 2026, 00:00 UTC
Bye bye Ozempic: Eli Lilly says its new drug retatrutide more than doubles weight loss
7.8% of FTXH
Yahoo! Finance · 27 Oct 2026, 23:28 UTC
$10,000 Invested in Eli Lilly 5 Years Ago Would Be Worth This Much Today
7.8% of FTXH

FTXH news

Where to buy FTXH

Where to buy FTXH